autoregulatory control of mitochondrial glutathione homeostasis Dual regulation SLC25A39 by AFG3L2 and iron controls Glutathione Depletion in Mitochondrial Diseases

No serious adverse events, hospitalization, organ damage, or deaths have been documented in over 100 preclinical studies, even at doses 1,000 times higher than typical therapeutic use

Continuous, daily usage without breaks is generally not recommended due to the lack of extensive human data and potential risks 1 2

Across models spanning tendons, ligaments, muscle, bone and the GI (gastrointestinal) tract, the same core mechanisms appear repeatedly, which is either a sign of genuine pleiotropic biology or publication bias

It works by protecting the liver from harmful chemical substances (free radicals), thus preventing liver damage

If a service is not appropriate, we will recommend a safer next step